|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.970 USD | -0.40% |
|
+77.50% | +19.47% |
| 06-29 | Galectin Therapeutics Inc.(NasdaqCM:GALT) added to Russell Small Cap Comp Growth Benchmark | CI |
| 06-29 | Galectin Therapeutics Inc.(NasdaqCM:GALT) added to Russell 2500 Growth Benchmark | CI |
| Market Cap | 327M 287M 265M 247M 465M 30.95B 476M 3.18B 1.23B 15.27B 1.23B 1.2B 53B | P/E 2026 * |
-13.4x | P/E 2027 * | -15.1x |
|---|---|---|---|---|---|
| Enterprise Value | 327M 287M 265M 247M 465M 30.95B 476M 3.18B 1.23B 15.27B 1.23B 1.2B 53B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
69.66% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Galectin Therapeutics Inc.
| 1 day | -0.40% | ||
| 1 week | +77.50% | ||
| Current month | +97.22% | ||
| 1 month | +97.22% | ||
| 3 months | +85.45% | ||
| 6 months | +21.81% | ||
| Current year | +19.47% |
| 1 week | 3.09 | 5.19 | |
| 1 month | 2.26 | 5.19 | |
| Current year | 2.02 | 5.19 | |
| 1 year | 2.02 | 7.13 | |
| 3 years | 0.73 | 7.13 | |
| 5 years | 0.73 | 7.13 | |
| 10 years | 0.49 | 9.49 |
| Manager | Title | Age | Since |
|---|---|---|---|
Joel Lewis
CEO | Chief Executive Officer | 56 | 01/09/2020 |
Jack Callicutt
DFI | Director of Finance/CFO | 58 | 30/06/2013 |
| Chief Tech/Sci/R&D Officer | - | 30/04/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Kevin Freeman
BRD | Director/Board Member | 65 | 30/04/2011 |
Benjamin Carson
BRD | Director/Board Member | 74 | 06/12/2023 |
Gilbert Omenn
BRD | Director/Board Member | 85 | 22/09/2014 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-22 | Fiscal year | Chief Technology Officer | 22,671 | 0.0344% | ||
| 05-25 | Fiscal year | Chief Technology Officer | 1,704 | 0.0026% | ||
| 03-11 | Other | Director | 0 | 0% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.40% | +77.50% | +113.30% | +257.55% | 329M | ||
| +0.94% | +7.83% | -4.77% | +3.17% | 46.2B | ||
| +5.79% | +16.17% | +421.86% | +634.63% | 38.71B | ||
| +1.12% | +15.18% | +22.74% | -12.71% | 31.9B | ||
| +3.61% | +6.69% | +20.23% | +62.38% | 31.12B | ||
| +8.02% | +6.35% | +17.67% | +34.73% | 23.77B | ||
| +1.13% | +15.66% | - | - | 16.2B | ||
| +1.45% | +17.35% | +72.11% | +127.60% | 15.05B | ||
| -1.13% | +7.40% | +12.03% | +20.67% | 13.74B | ||
| -0.60% | +6.32% | +102.74% | +96.28% | 13.42B | ||
| Average | +1.99% | +18.03% | +86.44% | +136.03% | 23.04B | |
| Weighted average by Cap. | +2.70% | +11.52% | +95.93% | +143.09% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | -24.6M -21.54M -19.88M -18.57M -34.95M -2.33B -35.75M -239M -92.38M -1.15B -92.38M -90.36M -3.98B | -22.9M -20.05M -18.51M -17.29M -32.54M -2.17B -33.28M -223M -85.99M -1.07B -86M -84.11M -3.71B |
| Net Debt | - | - |
Employees
9
| Date | Price | Change | Volume |
|---|---|---|---|
| 29/06/26 | US$4.970 | -0.40% | 1,852,576 |
| 26/06/26 | US$4.990 | +17.97% | 6,475,738 |
| 25/06/26 | US$4.230 | +7.91% | 1,856,659 |
| 24/06/26 | US$3.920 | +25.64% | 2,052,252 |
| 23/06/26 | US$3.120 | +11.43% | 3,906,157 |
Sell
Buy

Mean consensus
BUY
Number of Analysts
1
Last Close Price
4.980USD
Average target price
11.00USD
Spread / Average Target
+120.88%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GALT Stock
Select your edition
All financial news and data tailored to specific country editions

















